My tweak to your argument is that Acadia stuffed up guidance and...

First 13401 Last

Share
Profile

Follow
Wiji

173 Posts.

62

22/11/24

23:24

Post #: 76741646
Share

Originally posted by ajk92: ↑

Here’s a different opinion from someone who sold after the previous Acadia update, not the most recent one.

the quarterly wasn’t that good, it only just met guidance. To me that indicates a substantial lack of growth in the drugs sales. An increase of only maybe $5M? A new drug should not be petering out in terms of growth that quickly.

I know some will also point to that 70% of retts patients have yet to be put on the drug. You need to ask the question why such a large portion of the market has gone untreated. Have they been advised that the side effects do not outweigh the benefits? Surely they know about it by now, so you can’t put it down to informational frictions.

the milestone payment should have been factored in already. Even though it’s big, if it’s priced in, it shouldn’t result in a big gain.

the PRV was good though, as even though the amount could roughly be anticipated, the timing couldn’t have been (hence bringing forward a cash flow increasing it’s time value component).

I think the market overreacted to the recent news, and then throw in some momentum components, the drop was always going to be sharp. A friend of mine asked whether NEU should be added to the portfolio, and I still said no as I believed the quarterly was weak.

long term though, it should be a buy based on 2591. Picking the entry is a tough decision though as it locks up capital for a long time

Expand

My tweak to your argument is that Acadia stuffed up guidance and overshot which has caused all this drama. Working in corporate the first thing I learned was under promise and over deliver.

NEU Price at posting: $12.36 Sentiment: Buy Disclosure: Held
15 Upvote

0 Great analysis

Reply

Top Stories

NUZ

Neurizon inks $1.5M loan against R&D Tax Rebate

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

IXR

Ionic Rare Earths falls -7% as momentum slips on vague production update

HAR

Haranga jumps +7% on Lincoln acquisition

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

First 13401 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $16.63		Change -0.070(0.42%)		Mkt cap ! $2.095B

Open	High	Low	Value	Volume
$16.68	$16.86	$16.51	$4.012M	240.7K

Buyers (Bids)

No.	Vol.	Price($)
2	982	$16.60

Sellers (Offers)

Price($)	Vol.	No.
$16.66	1000	1

View Market Depth

No.	Vol.	Price($)
1	13	17.160
1	30	16.700
2	246	16.660
2	91	16.630
1	44	16.600

Price($)	Vol.	No.
16.650	161	1
16.660	1000	1
16.700	67	1
16.770	288	2
16.800	703	1

Last trade - 16.10pm 30/07/2025 (20 minute delay)

NEU (ASX) Chart

My tweak to your argument is that Acadia stuffed up guidance and...

Neurizon inks $1.5M loan against R&D Tax Rebate

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

Ionic Rare Earths falls -7% as momentum slips on vague production update

Haranga jumps +7% on Lincoln acquisition

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

My tweak to your argument is that Acadia stuffed up guidance and...

Top Stories

Neurizon inks $1.5M loan against R&D Tax Rebate

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

Ionic Rare Earths falls -7% as momentum slips on vague production update

Haranga jumps +7% on Lincoln acquisition

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News